Bioneer Corporation (KQ:064550) — Market Cap & Net Worth
Market Cap & Net Worth: Bioneer Corporation (064550)
Bioneer Corporation (KQ:064550) has a market capitalization of $147.65 Million (₩217.88 Billion) as of September 17, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17802 globally and #745 in its home market, demonstrating a -6.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioneer Corporation's stock price ₩9860.00 by its total outstanding shares 22097400 (22.10 Million). Also see total assets of Bioneer Corporation for a full breakdown of the balance sheet.
Bioneer Corporation Market Cap History: 2015 to 2026
Bioneer Corporation's market capitalization history from 2015 to 2026. Data shows growth from $137.48 Million to $147.65 Million (0.93% CAGR). Also see Bioneer Corporation cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Bioneer Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$231.82 Billion | 0.06% | #268 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$231.82 Billion | 0.06% | #268 of 1384 |
Weight: Bioneer Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bioneer Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioneer Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 064550 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Bioneer Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $137.48 Million | $20.83 Billion | -$5.37 Billion | 0.01x | N/A |
| 2016 | $102.66 Million | $21.70 Billion | -$14.42 Billion | 0.00x | N/A |
| 2017 | $134.78 Million | $23.27 Billion | -$9.87 Billion | 0.01x | N/A |
| 2018 | $111.26 Million | $24.08 Billion | -$8.82 Billion | 0.00x | N/A |
| 2019 | $101.68 Million | $36.29 Billion | -$7.83 Billion | 0.00x | N/A |
| 2020 | $265.81 Million | $206.99 Billion | $57.90 Billion | 0.00x | 0.00x |
| 2021 | $727.79 Million | $223.74 Billion | $27.16 Billion | 0.00x | 0.03x |
| 2022 | $440.27 Million | $218.39 Billion | $12.08 Billion | 0.00x | 0.04x |
| 2023 | $498.67 Million | $263.24 Billion | -$10.59 Billion | 0.00x | N/A |
| 2024 | $282.28 Million | $293.98 Billion | -$20.58 Billion | 0.00x | N/A |
Competitor Companies of 064550 by Market Capitalization
Companies near Bioneer Corporation in the global market cap rankings as of September 17, 2026. Review 064550 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Bioneer Corporation by market ranking:
- Peptron Inc (KQ:087010): Ranked #7067 globally with a market cap of $1.57 Billion USD ( ₩2.31 Trillion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19636 globally with a market cap of $90.68 Million USD ( ₩133.80 Billion KRW).
- Cell Biotech Co. Ltd (KQ:049960): Ranked #20066 globally with a market cap of $81.77 Million USD ( ₩120.66 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #20165 globally with a market cap of $79.80 Million USD ( ₩117.75 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7067 | Peptron Inc | KQ:087010 | $1.57 Billion | ₩150800.00 |
| #19636 | MEDIPOST Co. Ltd | KQ:078160 | $90.68 Million | ₩8700.00 |
| #20066 | Cell Biotech Co. Ltd | KQ:049960 | $81.77 Million | ₩15630.00 |
| #20165 | Macrogen Inc | KQ:038290 | $79.80 Million | ₩11750.00 |
Bioneer Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Bioneer Corporation's market cap moved from $137.48 Million to $ 147.65 Million, with a yearly change of 0.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩147.65 Million | -22.67% |
| 2025 | ₩190.93 Million | -32.36% |
| 2024 | ₩282.28 Million | -43.39% |
| 2023 | ₩498.67 Million | +13.27% |
| 2022 | ₩440.27 Million | -39.51% |
| 2021 | ₩727.79 Million | +173.80% |
| 2020 | ₩265.81 Million | +161.41% |
| 2019 | ₩101.68 Million | -8.61% |
| 2018 | ₩111.26 Million | -17.44% |
| 2017 | ₩134.78 Million | +31.29% |
| 2016 | ₩102.66 Million | -25.33% |
| 2015 | ₩137.48 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Bioneer Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.65 Million USD |
| MoneyControl | $147.65 Million USD |
| MarketWatch | $147.65 Million USD |
| marketcap.company | $147.65 Million USD |
| Reuters | $147.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bioneer Corporation
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analys… Read more